Filing Analysis
Mobix Labs, Inc. announced preliminary Q3 2026 revenue guidance of $750k-$850k and Q4 2026 revenue guidance of $1.4M-$1.8M during an investor call. The company is currently finalizing its financial results for the quarter ended June 30, 2026.
🚩 Red Flags
- Explicit mention of 'risks concerning our ability to continue as a going concern' in forward-looking statements.
- Risk regarding inability to meet future capital requirements or raise additional capital on attractive terms.
- Potential dilutive impact on stockholders mentioned in risk disclosures.
📋 Key Facts
- Preliminary Q3 2026 revenue guidance: $750,000 - $850,000.
- Preliminary Q4 2026 revenue guidance: $1.4 million - $1.8 million.
- The company is still reviewing and finalizing financial results for the quarter ended June 30, 2026.
- Management discussed strategic direction of the business via press release (Exhibit 99.1).
Mobix Labs, Inc. entered into a definitive merger agreement to acquire Vision Aerial, Inc. via a two-step merger involving two subsidiaries.
🚩 Red Flags
- The transaction involves significant dilution through the issuance of shares valued at up to $12 million.
- The use of a VWAP-based share price with a floor/cap mechanism can lead to unpredictable dilution for existing shareholders depending on market volatility.
📋 Key Facts
- The transaction is structured as a reorganization under Section 368(a) of the Internal Revenue Code.
- Total consideration includes $12 million in Class A common stock and $3 million in cash, subject to adjustments.
- The share price for calculating stock consideration (Rollover Share Price) is based on the 20-day VWAP, with a floor of $2.00 and a cap of $3.00 per share.
- Closing is subject to stockholder approval from both Mobix Labs and Vision Aerial, as well as due diligence satisfaction.
Mobix Labs, Inc. issued a $2.8 million senior secured convertible promissory note to Leviston Resources, LLC on June 22, 2026. The deal includes highly dilutive conversion terms and is part of an existing investor rights agreement.
🚩 Red Flags
- Highly dilutive conversion feature (85% of the lowest 8-day VWAP).
- Short-term debt maturity (October 2026) creates immediate liquidity pressure.
- Senior secured status gives the lender priority over other unsecured creditors/shareholders.
- Deregistration of 950,000 shares from a previous equity line suggests management is managing existing overhang or capital structure shifts.
📋 Key Facts
- Issued a senior secured convertible promissory note to Leviston Resources, LLC.
- Original principal amount: $2.8 million; gross proceeds to Company: approximately $2.3 million.
- Interest rate: 10% per annum.
- Maturity date: October 18, 2026 (short-term maturity of ~4 months).
- Conversion price: Lesser of the closing price on June 22, 2026, or 85% of the lowest eight-day VWAP.
- The note is secured and subject to stockholder approval.
Mobix Labs provided a comprehensive business update detailing ongoing negotiations to acquire Vision Aerial, Inc., planned corrective amendments to a financing deal with Kips Bay Select LP, and an upcoming July 2026 stockholder meeting to approve significant equity issuances.
🚩 Red Flags
- High dilution risk: The company is seeking stockholder approval for multiple large-scale equity issuances and future fundraising transactions.
- Funding uncertainty: The company admits it has not entered into definitive agreements for new financing and there is no assurance capital can be raised on acceptable terms.
- Execution risk: The Vision Aerial acquisition is non-binding and subject to numerous conditions, including the availability of financing.
- Corrective amendments: The need for a 'corrective amendment' to the Kips transaction documents to fix 'scrivener's errors' suggests potential administrative instability.
📋 Key Facts
- Active negotiations are ongoing for the acquisition of Vision Aerial, Inc., though no definitive agreement has been signed.
- The company intends to file a resale registration statement (Form S-1) for approximately 3,300,000 shares for Kips Bay Select LP and 1,239,613 shares for five other stockholders.
- A stockholder meeting is planned for July 2026 to vote on the Kips transaction, charter amendments regarding Class B stock, and increasing the equity incentive plan.
- The company explicitly stated it expects to seek additional capital in the near future to fund M&A and working capital.
- The company recently settled two lawsuits and satisfied approximately $3.74 million in debt liabilities.
Mobix Labs, Inc. (MOBX) filed a multi-item 8-K disclosing a first amendment to its senior secured convertible note with Leviston Resources, LLC, increasing the principal from $3 million to $4 million in exchange for an additional $833,333 cash advance. The full $4 million principal was subsequently converted into 2,500,000 shares of Class A Common Stock between May 12–18, 2026, satisfying the note in full. Additionally, a new Investor Rights Agreement grants Leviston the option to acquire up to $4 million in additional secured convertible notes over a seven-month period, preserving ongoing dilution risk.
🚩 Red Flags
- Variable conversion price formula on the convertible note is a hallmark of 'death spiral' or toxic financing structures common in distressed micro-caps.
- 2,500,000 newly issued shares were immediately resold by Leviston into the public market, creating significant selling pressure.
- New Investor Rights Agreement preserves Leviston's ability to deploy up to $4 million in additional secured convertible notes over seven months — dilution risk is NOT eliminated.
- Four separate 8-K items in a single filing (1.01, 1.02, 2.03, 3.02) — a red flag escalator.
- Additional convertible notes under the Investor Rights Agreement would be secured on a 'pari passu basis,' meaning senior secured claims would grow with each new issuance.
- The CFO and President are the same individual (Keyvan Samini), suggesting a lean or potentially strained executive structure.
- Company has relied on multiple rounds of convertible note financing in a short period (March → May 2026), indicating potential liquidity stress.
- Section 3(a)(9) exemption used for share issuances bypasses typical investor protections associated with registered offerings.
📋 Key Facts
- On May 13, 2026, Mobix Labs amended its senior secured convertible note with Leviston Resources, LLC, increasing principal from $3 million to $4 million in exchange for an additional $833,333 cash advance.
- The Original Note was first issued March 31, 2026, with a variable conversion price formula previously disclosed in an 8-K filed April 3, 2026.
- Between May 12–18, 2026, Leviston converted the entire $4 million principal plus accrued interest into 2,500,000 shares of Class A Common Stock.
- The note, Securities Purchase Agreement (dated March 31, 2026), and Registration Rights Agreement all terminated upon full satisfaction on May 18, 2026.
- A new Investor Rights Agreement grants Leviston the right to acquire up to $4.0 million in additional secured convertible notes over a seven-month period on substantially similar terms.
- Leviston's beneficial ownership was capped at 4.99% of outstanding Class A Common Stock at any time.
- Share issuances were exempt from registration under Section 3(a)(9) of the Securities Act.
- New shares were resold by Leviston pursuant to the Company's effective Registration Statement on Form S-1.
- Filing covers Items 1.01, 1.02, 2.03, and 3.02 — four separate 8-K items.
- Signed by Keyvan Samini, President and CFO, on May 19, 2026.
Mobix Labs, Inc. implemented a 1-for-10 reverse stock split of its Class A and Class B common stock effective April 6, 2026. The split includes proportional adjustments to the company's equity incentive plans and outstanding warrants.
🚩 Red Flags
- Reverse stock split (1:10 ratio) is a significant red flag often used to artificially inflate share price to meet exchange listing requirements.
- The adjusted warrant exercise price of $57.90 suggests the pre-split share price was significantly depressed.
📋 Key Facts
- The 1-for-10 reverse stock split became effective at 4:00 p.m. Eastern Time on April 6, 2026.
- The CUSIP number for the Common Stock changed to 60743G209.
- Public and private placement warrants are now exercisable for 1/10th of a share at an adjusted exercise price of $57.90 per share.
- No fractional shares will be issued; stockholders will receive cash in lieu of fractional shares.
- The par value remains $0.00001 per share and the authorized number of shares remains unchanged.
Mobix Labs issued a $3,000,000 senior secured convertible promissory note to Leviston Resources, LLC for $2,550,000 in proceeds, representing a 15% original issue discount. The note carries a 10% interest rate and matures in only four months on July 31, 2026, with highly dilutive conversion terms.
🚩 Red Flags
- Death spiral financing characteristics: The conversion price is pegged to 85% of the lowest 8-day VWAP, which can lead to massive dilution if the stock price declines.
- Significant Original Issue Discount (OID): The company paid $450,000 in immediate value to secure $2,550,000 in cash.
- Extremely short-term maturity: A four-month maturity suggests urgent liquidity needs or an inability to secure long-term financing.
- Senior secured status: The debt is secured, placing this lender ahead of other stakeholders in the capital structure.
📋 Key Facts
- Principal amount of $3,000,000 issued for a purchase price of $2,550,000.
- The note matures on July 31, 2026, providing a very short runway of approximately 120 days.
- Conversion price is the lesser of the March 31, 2026 closing price or 85% of the lowest 8-day VWAP prior to conversion.
- Default penalty increases the outstanding obligation to 125% of the then-current amount.
- The company must file a registration statement for the underlying shares within 14 days.
Mobix Labs, Inc. held its Annual Meeting on March 23, 2026, where stockholders approved a reverse stock split and a warrant proposal. The meeting also confirmed the election of directors and ratified the company's independent auditor.
🚩 Red Flags
- Approval of a reverse stock split, which is frequently a defensive measure to avoid delisting due to a low share price.
- Dual-class share structure providing concentrated voting power to Class B holders (e.g., Keyvan Samini, who is also President and CFO).
📋 Key Facts
- Stockholders approved a Reverse Stock Split Proposal (Proposal No. 3) on March 23, 2026.
- Stockholders approved the Warrant Proposal (Proposal No. 4).
- David Aldrich and Frederick Goerner were elected as Class A Directors; Keyvan Samini was elected as Class B Director.
- A quorum was established with 52.86% of the voting power represented.
- Class B Common Stock appears to hold 10-to-1 voting power, as 2,004,901 shares represented 20,049,010 votes for the Class B Director.
Mobix Labs, Inc. amended its bylaws to significantly reduce the quorum requirement for stockholder meetings from a majority to one-third of the voting power. This change was approved by the Board of Directors and became effective on February 27, 2026.
🚩 Red Flags
- Reducing quorum requirements to one-third is a common tactic for companies struggling to achieve shareholder participation or seeking to pass measures with limited consensus.
- This change allows corporate actions to be approved by a smaller fraction of the total shareholder base, potentially diluting the influence of minority shareholders.
📋 Key Facts
- The Board of Directors approved the amendment and restatement of the Company’s bylaws on February 27, 2026.
- The quorum requirement for stockholder meetings was reduced from a majority (50%+) to one-third (33.3%) of the voting power of outstanding shares.
- The amendment applies to all meetings of stockholders unless otherwise provided by statute, the certificate of incorporation, or stock exchange regulations.
- The company is classified as an emerging growth company and is listed on the Nasdaq Capital Market.
Mobix Labs, Inc. entered into agreements for a public offering of 30,000,000 shares of Class A common stock at $0.20 per share. The net proceeds are expected to be approximately $5.135 million, intended for working capital and general corporate purposes.
🚩 Red Flags
- Significant dilution: Issuance of 30 million shares at a very low price ($0.20) suggests heavy dilution for existing shareholders.
- Low share price: The $0.20 offering price is extremely low, often characteristic of companies facing liquidity constraints or struggling to maintain minimum bid requirements.
📋 Key Facts
- Offering size: 30,000,000 shares of Class A common stock.
- Offering price: $0.20 per share.
- Net proceeds: Approximately $5,135,000 after fees and expenses.
- Placement Agent: D. Boral Capital LLC (8.0% cash fee + 1.0% expense reimbursement cap).
- Lock-up period: Executive officers and directors are subject to a 30-day lock-up following the closing date.
- Negative covenants: Company is restricted from issuing new securities or variable rate transactions for 30-60 days post-closing.
Mobix Labs, Inc. announced the launch and subsequent pricing of a public offering of its common stock on January 5 and January 6, 2026, respectively.
🚩 Red Flags
- Potential dilution for existing shareholders due to the issuance of new common stock.
📋 Key Facts
- Announced launch of a public offering of common stock on January 5, 2026.
- Announced the pricing of the Offering on January 6, 2026.
- The company is an emerging growth company.
- The filing includes press releases regarding the offering (Exhibits 99.1 and 99.2).
Mobix Labs, Inc. filed an 8-K to announce the release of its financial results for the fiscal year ended September 30, 2025.
📋 Key Facts
- The filing is a standard announcement of annual financial results (Item 2.02).
- Fiscal year end date: September 30, 2025.
- Report date: December 1, 2025; Filing date: December 4, 2025.
- The company is an emerging growth company.
Mobix Labs, Inc. has received a 180-day extension from Nasdaq to regain compliance with the minimum bid-price requirement ($1.00/share) through April 27, 2026. The company is simultaneously executing several balance sheet restructuring actions, including debt-for-equity swaps and warrant amendments, to improve its capital structure and meet stockholders' equity standards.
🚩 Red Flags
- Ongoing Nasdaq delisting risk regarding the minimum bid-price requirement.
- Significant dilution potential from the issuance of over 13 million amended warrants and new warrants totaling 2.3M+ shares in recent restructuring/amendments.
- Heavy reliance on equity issuances to settle debt (debt-for-equity swaps) which can signal liquidity constraints.
📋 Key Facts
- Nasdaq granted an extension for the Minimum Bid-Price Requirement until April 27, 2026.
- The company amended warrants held by Armistice Capital Master Fund Ltd. to reclassify ~$6.3 million from liabilities to equity.
- Issued an additional warrant to purchase 1,000,000 shares of Class A common stock at an exercise price of $1.08.
- Executed a debt-for-equity exchange with Acromax, Inc. for $204,931.07 in obligations using 227,954 shares.
- Executed a debt-for-equity exchange with Alessandra Investment Trust II for $510,791.67 in indebtedness using 687,894 shares.
Mobix Labs, Inc. entered into an At The Market (ATM) offering agreement with Roth Capital Partners, LLC to sell up to $15.8 million in Class A common stock. The proceeds are intended for general working capital purposes.
🚩 Red Flags
- Potential for significant shareholder dilution through the ATM offering.
- The use of proceeds for 'working capital' often indicates a need to fund ongoing operational burn rather than specific growth-oriented acquisitions.
📋 Key Facts
- Agreement date: October 21, 2025
- Maximum offering amount: $15.8 million
- Manager: Roth Capital Partners, LLC
- Commission rate: 3.0% of gross sales proceeds
- Expense reimbursement to Manager: Up to $75,000
- Use of proceeds: Working capital purposes
- Registration basis: Effective Form S-3 (File No. 333-284351) filed Jan 17, 2025
Mobix Labs, Inc. entered into a warrant exercise inducement offer to raise approximately $4.5 million in gross proceeds. The deal involves the issuance of significant new warrants to an existing holder and a placement agent in exchange for the immediate exercise of existing warrants.
🚩 Red Flags
- Significant potential dilution: The issuance of over 8 million new inducement warrants represents a substantial increase in the potential common share count.
- Warrant Overhang: The deal structure involves 'warrants for warrants,' which is often used by companies facing liquidity constraints to prevent immediate mass dilution while securing near-term cash.
- Requirement for stockholder approval: The company's inability to issue these warrants without a shareholder vote suggests the scale of the issuance exceeds authorized limits or triggers specific governance requirements.
📋 Key Facts
- The company expects to receive approximately $4.5 million in aggregate gross proceeds from the exercise of Existing Warrants.
- Existing Warrants cover up to 5,486,467 shares at an exercise price of $0.8202 per share.
- In exchange, the Company will issue new 'Inducement Warrants' for up to 8,229,701 shares with an exercise price of $1.08 per share.
- Roth Capital Partners, LLC is acting as financial advisor and receiving a 7.0% cash placement fee plus warrants for 384,053 shares at $1.08 per share.
- The company must seek stockholder approval for the Inducement Warrants via a meeting within 60 days of closing.
Mobix Labs, Inc. filed an 8-K/A to correct a material error regarding the conversion terms of a secured promissory note with Lendspark. The amendment clarifies that Lendspark has the right to convert its $550,000 note into equity at any time, rather than only upon default.
🚩 Red Flags
- Material error correction: The original filing misrepresented the conversion rights of a major debt instrument (Lendspark Note).
- High dilution risk: Lendspark's ability to convert at any time into up to 2.5M shares at $0.70 represents significant potential dilution.
- Heavy encumbrance: Both Lendspark and Maxim financing are secured by 'substantially all assets' or 'all assets' of the company.
- Collateral pledge: 1,500,000 shares pledged to Maxim as collateral in case of default.
📋 Key Facts
- Amended 8-K filed on September 3, 2025, to correct an error in a previous filing from August 21, 2025.
- Lendspark Note: $550,000 secured promissory note; convertible at any time into up to 2,500,000 shares of Class A Common Stock at $0.70 per share.
- Maxim Financing: $600,000 loan from Maximcash Solutions LLC secured by all company assets; includes 93,750 commitment shares and 1,500,000 pledged shares as collateral.
- Accredited Investor Investment: Sale of 1,052,725 shares at $0.95 per share (approx. $1.0 million gross proceeds) plus a warrant for 500,045 shares at $0.96 per share.
- The company issued significant equity as commitment shares and warrants across multiple financing rounds in August 2025.
Mobix Labs, Inc. completed three distinct financing transactions in August 2025 to bolster working capital, involving secured promissory notes and equity sales. These transactions include significant debt components with conversion features and collateralized assets.
🚩 Red Flags
- High dilution risk: The Lendspark note allows conversion into up to 2.5M shares upon default, significantly diluting existing shareholders.
- Asset-backed debt: Both the Lendspark and Maxim loans are secured by substantially all assets of the Company.
- Pledged collateral: 1.5 million shares have been pledged as additional collateral to Maxim in the event of default.
- Make-whole provisions: The Lendspark note contains 'make-whole' clauses that could trigger further share issuances or cash payments.
📋 Key Facts
- Lendspark Financing: $550,000 secured promissory note maturing in 12 months; includes 150,000 commitment shares and a potential conversion into up to 2,500,000 shares at $0.70/share upon default.
- Maxim Financing: $600,000 Business Loan from Maximcash Solutions LLC secured by all company assets; includes 93,750 commitment shares and 1,500,000 shares pledged as collateral.
- Accredited Investor Equity Investment: Sale of 1,052,725 shares at $0.95 per share for ~$1.0 million gross proceeds; includes a warrant for 500,045 shares at $0.96/share.
- Total immediate liquidity raised via these transactions is approximately $2.15 million.
Mobix Labs, Inc. announced the appointment of CEO Philip Sansone to the Board of Directors and disclosed that Mr. Sansone personally guaranteed a $600,000 loan for the company on August 13, 2025.
🚩 Red Flags
- Related-party transaction: The CEO has personally guaranteed a $600,000 loan to the company, indicating potential liquidity or credit constraints requiring personal guarantees from management.
- Management instability/transition: The CEO moved from Interim CEO (April 2025) to permanent CEO (July 2025) in a very short timeframe.
📋 Key Facts
- Philip Sansone appointed as Class I director effective August 8, 2025; term expires at 2028 Annual Meeting.
- Mr. Sansone has served as CEO since July 2025 (previously Interim CEO from April to July 2025).
- On August 13, 2025, the CEO personally guaranteed a $600,000 loan for the Company.
- The company is an emerging growth company.
Mobix Labs, Inc. filed an amendment to its 8-K to correct a previous error regarding the departure of CEO Fabian Battaglia. Mr. Battaglia resigned from both his CEO role and the Board of Directors effective July 25, 2025.
🚩 Red Flags
- Sudden departure of the Chief Executive Officer (CEO).
- Significant severance/benefit package including 36 months of COBRA coverage.
- The filing is an 'Amendment No. 1' to correct a previous error, indicating potential administrative or communication lapses in earlier disclosures.
📋 Key Facts
- CEO Fabian Battaglia stepped down as CEO and resigned from the Board effective July 25, 2025.
- The departure is not due to any disagreement with the Company regarding operations, policies, or practices.
- Mr. Battaglia will remain as a senior advisor and consultant to the CEO and Board until December 31, 2026.
- The Company will continue to pay health benefits (COBRA) for Mr. Battaglia and his spouse for 36 months.
- Mr. Battaglia retains all previously granted equity awards.
Mobix Labs, Inc. announced a leadership transition where CEO Fabian Battaglia is stepping down effective July 25, 2025, to serve as a consultant through late 2026. Philip Sansone, previously the Interim CEO and VP of Worldwide Sales, has been appointed permanent CEO.
🚩 Red Flags
- CEO departure often introduces uncertainty regarding strategic direction.
- Significant severance/benefit package: The company is committed to paying 36 months of COBRA benefits for the outgoing CEO.
📋 Key Facts
- Fabian Battaglia steps down as CEO effective July 25, 2025.
- Battaglia to remain as senior advisor/consultant until December 31, 2026.
- Company will continue paying health benefits (COBRA) for Mr. Battaglia and his spouse for 36 months.
- Philip Sansone appointed CEO effective July 25, 2025.
- Sansone previously served as Interim CEO since April 2025 and VP of Worldwide Sales since September 2021.
- Compensation arrangements for the new CEO are not yet finalized and will be disclosed in a future amendment.
Mobix Labs, Inc. has issued an unsolicited, non-binding proposal to acquire Peraso Technologies Inc. via a stock-for-stock transaction at a 20% premium to Peraso's recent average closing price.
🚩 Red Flags
- Transaction is 'non-binding,' meaning there is no guarantee the deal will proceed or be accepted by Peraso's board.
- Potential for significant dilution of existing MOBX shareholders due to the issuance of new common shares for the acquisition.
📋 Key Facts
- Unsolicited, non-binding proposal to acquire Peraso Technologies Inc. (Nasdaq: PRSO).
- Transaction structure is proposed as a stock-for-stock exchange.
- Proposed premium of 20% over Peraso's 30-day average closing price through June 10, 2025.
- The announcement was made via press release on June 26, 2025.
Mobix Labs, Inc. filed an amendment to its previous 8-K to correct a calculation error regarding voting results from its May 30, 2025, special meeting of stockholders. While the corrected figures were provided, the company noted that the outcome of the proposals remains unchanged.
🚩 Red Flags
- Calculation error in previous SEC filing regarding stockholder voting results.
📋 Key Facts
- The filing is an amendment (8-K/A) to a report filed on June 5, 2025.
- Corrected voting results were provided by an outside tabulation firm due to a calculation error in the original filing.
- Proposal No. 1 (2025 Warrant Exercise Proposal): Approved with 35,584,855 votes 'For'.
- Proposal No. 2 (Warrant Repricing Proposal): Approved with 35,586,052 votes 'For'.
- Proposal No. 3 (Equity Grant Proposal): Approved with 31,441,995 votes 'For'.
- Quorum was established by holders of approximately 59.2% of the voting power as of May 6, 2025.
Mobix Labs, Inc. held a Special Meeting of Stockholders on May 30, 2025, where shareholders approved three major proposals related to warrant exercises and equity incentives. The meeting resulted in the approval of the 2025 Warrant Exercise Proposal, the Warrant Repricing Proposal, and the Equity Grant Proposal.
🚩 Red Flags
- Warrant Repricing: Approval of a repricing proposal often suggests the company is adjusting terms to make warrants more attractive or to prevent expiration, which can lead to significant dilution for existing shareholders.
📋 Key Facts
- Special Meeting held on May 30, 2025.
- Quorum represented ~59.2% of voting power (17,052,157 Class A shares and 2,041,666 Class B shares).
- Proposal 1 (2025 Warrant Exercise Proposal) approved with 35,584,855 votes 'For'.
- Proposal 2 (Warrant Repricing Proposal) approved with 35,584,855 votes 'For'.
- Proposal 3 (Equity Grant Proposal/2023 Warrant Exercise) approved with 35,586,052 votes 'For'.
Mobix Labs, Inc. received delinquency notices from Nasdaq for failing to meet the minimum bid price requirement ($1.00) and the minimum market value of listed securities (MVLS) requirement ($35 million). The company has a 180-day compliance period ending October 27, 2025, to rectify these issues.
🚩 Red Flags
- Failure to maintain minimum bid price (Nasdaq Rule 5550(a)(2)).
- Failure to maintain minimum market value of listed securities (Nasdaq Rule 5550(b)(2)).
- Risk of delisting if compliance is not met within the 180-day window or a subsequent second period.
📋 Key Facts
- Received two delinquency notification letters from Nasdaq Listing Qualifications Staff on April 28, 2025.
- Failed Minimum Bid Price Requirement: Common Stock bid price below $1.00 for 30 consecutive business days.
- Failed MVLS Requirement: Market value of listed securities below $35 million for 30 consecutive business days.
- Compliance period established: 180 calendar days, expiring October 27, 2025.
- To regain compliance, the stock must meet/exceed $1.00 or MVLS must reach $35M for at least ten consecutive business days.
Mobix Labs, Inc. announced the appointment of Philip Sansone as Interim CEO effective April 10, 2025. This change follows the departure of current CEO Fabian Battaglia, who is currently on sick leave.
🚩 Red Flags
- Sudden leadership change due to CEO being on 'sick leave' creates management uncertainty and potential key-person risk.
📋 Key Facts
- Philip Sansone appointed as Interim Chief Executive Officer effective April 10, 2025.
- Interim CEO will serve until current CEO Fabian Battaglia returns from sick leave.
- Mr. Sansone previously served as VP of Worldwide Sales at Mobix Labs from September 2021 to April 2025.
- The appointment is not part of any specific arrangement or understanding with third parties.
Mobix Labs, Inc. entered into a registered direct offering and private placement to raise approximately $4 million in gross proceeds. The deal includes the issuance of common stock, pre-funded warrants, and unregistered common warrants, alongside an amendment to existing warrants that significantly reduces their exercise price.
🚩 Red Flags
- Significant dilution: The issuance of millions of new shares and warrants will substantially increase the total share count.
- Warrant Down-round/Refixing: Reducing existing warrant exercise prices from $1.39 to $0.8202 is a strong signal of distressed financing or significant downward pressure on stock price.
- Unregistered securities: The inclusion of unregistered common warrants (Item 3.02) indicates private placement components that may lead to future liquidity/selling pressure once registered.
📋 Key Facts
- Registered Direct Offering: 3,850,000 shares at $0.8202 per share.
- Pre-Funded Warrants: 1,026,860 warrants to purchase shares at $0.0001 exercise price.
- Common Warrants: Up to 4,876,860 unregistered common warrants with an exercise price of $0.8202.
- Gross proceeds expected to be approximately $4 million before fees.
- Placement Agent (Roth Capital Partners, LLC) to receive a 7.0% cash fee and warrants for up to 682,760 shares at $0.8202.
- Existing Series A and B Warrants exercise price reduced from $1.39 to $0.8202 per share.
Mobix Labs, Inc. held its Annual Meeting of Stockholders on March 3, 2025. The meeting resulted in the successful election of directors and the ratification of the independent registered public accounting firm.
📋 Key Facts
- Annual Meeting held on March 3, 2025.
- Quorum established by holders of approximately 67.2% of voting power (32,904,780 Class A and 2,129,901 Class B shares).
- Proposal 1: Director Election Proposal was approved; Kurt Busch, William Carpou, and Fabrizio Battaglia were elected.
- Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm was approved with 36,247,381 votes in favor.
Mobix Labs, Inc. filed an 8-K to furnish its quarterly press release for the fiscal quarter ended December 31, 2024. The filing is a standard disclosure of financial results under Item 2.02.
📋 Key Facts
- The company released financial results for the fiscal quarter ended December 31, 2024.
- The press release was issued on February 18, 2025.
- The filing is pursuant to Item 2.02 (Results of Operations and Financial Condition).
- The company is an emerging growth company.
Mobix Labs, Inc. announced it has entered into a non-binding letter of intent (LOI) to acquire SCP Manufacturing, a producer of electrical components for aerospace and defense sectors.
🚩 Red Flags
- Transaction is currently non-binding (LOI stage), meaning the deal could fail during due diligence.
📋 Key Facts
- Entered into a non-binding Letter of Intent (LOI) on January 22, 2025.
- Target company is SCP Manufacturing, based in Nevada.
- SCP Manufacturing specializes in mission-critical electrical components for aerospace, defense, and commercial applications.
- The transaction is subject to definitive agreement and final due diligence.
Mobix Labs, Inc. filed an 8-K to provide updated unaudited pro forma condensed combined financial statements for the fiscal year ended September 30, 2024, reflecting the impact of its December 18, 2023, acquisition of EMI Solutions, Inc.
📋 Key Facts
- The filing provides updated unaudited pro forma condensed combined statement of operations for the year ended September 30, 2024.
- The financial updates are specifically related to the acquisition of EMI Solutions, Inc. completed on December 18, 2023.
- The company is an emerging growth company.
Mobix Labs, Inc. held a Special Meeting of Stockholders on January 3, 2025, to vote on five proposals regarding equity grants and warrant exercises. Four out of the five proposals were approved by stockholders, while one amendment to the Certificate of Incorporation was rejected.
🚩 Red Flags
- Rejection of Proposal 5 (Certificate of Incorporation Amendment) suggests shareholder disagreement with certain structural changes or governance amendments.
📋 Key Facts
- Special Meeting held on January 3, 2025.
- Quorum represented approximately 66.2% of voting power (14,582,869 Class A and 2,129,901 Class B shares).
- Proposal 1 (Equity Grant Proposal) was approved: 28,804,349 For / 5,473,784 Against.
- Proposal 2 (Equity Incentive Plan Amendment) was approved: 32,932,649 For / 2,912,915 Against.
- Proposal 3 (2023 Warrant Exercise Proposal) was approved: 34,066,211 For / 1,804,924 Against.
- Proposal 4 (2024 Warrant Exercise Proposal) was approved: 35,613,502 For / 263,464 Against.
- Proposal 5 (Certificate of Incorporation Amendment) was NOT approved: 35,685,144 Against / 175,808 For.
Mobix Labs, Inc. filed an 8-K to furnish its press release announcing financial results for the fiscal year ended September 30, 2024.
📋 Key Facts
- The filing relates to the announcement of financial results for the fiscal year ended September 30, 2024.
- The report was filed on December 19, 2024.
- Information provided under Item 2.02 is furnished but not 'filed' for purposes of Section 18 of the Exchange Act.
Mobix Labs, Inc. announced it has entered into a non-binding letter of intent (LOI) to acquire Spacecraft Components Corp., a provider of high-precision components for the aerospace and defense sectors.
🚩 Red Flags
- Transaction is non-binding (LOI stage), meaning there is no guarantee the deal will close.
- Subject to further due diligence which may reveal liabilities or valuation issues.
📋 Key Facts
- Entered into a non-binding Letter of Intent (LOI) on November 25, 2024.
- Target company is Spacecraft Components Corp., based in Nevada.
- Target specializes in mission-critical components for aerospace, defense, and commercial applications.
- The transaction is subject to definitive agreement and final due diligence.
Mobix Labs, Inc. received a delinquency notification from Nasdaq for failing to maintain the minimum $1.00 bid price requirement. The company has 180 days to regain compliance or face potential delisting.
🚩 Red Flags
- Non-compliance with Nasdaq's $1.00 Minimum Bid Price Requirement.
- History of non-compliance: Previously failed to maintain minimum Market Value of Listed Securities ($50M) between June and August 2024.
- Potential for a reverse stock split to regain compliance, which is often dilutive or psychologically negative for shareholders.
📋 Key Facts
- Received delinquency notice on November 18, 2024, regarding Nasdaq Listing Rule 5450(a)(1).
- The company must maintain a closing bid price of at least $1.00 for ten consecutive business days within the next 180 days to regain compliance.
- The deadline to meet this requirement is May 19, 2025 (Note: Filing text contains a likely typo stating 'May 19, 2024', but context implies 2025).
- Failure to comply may lead to delisting or the need to transfer to the Nasdaq Capital Market.
- The company previously received a delinquency notice on August 9, 2024, regarding minimum market value requirements.
Mobix Labs, Inc. filed an 8-K to announce preliminary financial results for the fiscal fourth quarter and year ended September 30, 2024, alongside a press release regarding company growth.
📋 Key Facts
- Company announced preliminary financial results for Q4 and FY 2024 on October 15, 2024.
- Issued a press release discussing '2024 growth' on October 17, 2024.
- The filing includes Exhibit 99.1 (financial results) and Exhibit 99.2 (growth discussion).
Mobix Labs, Inc. announced it has submitted a non-binding proposal to acquire all outstanding shares of EMCORE Corporation. The filing clarifies that this is a preliminary business combination proposal and not an official offer or solicitation.
🚩 Red Flags
- The proposal is 'non-binding,' meaning there is no legal obligation for the transaction to proceed, creating high uncertainty for shareholders.
📋 Key Facts
- On September 30, 2024, Mobix Labs, Inc. announced a non-binding proposal to acquire EMCORE Corporation.
- The proposal aims to acquire all outstanding shares of Emcore.
- The announcement is subject to future developments and potential SEC filings including registration statements or proxy statements.
- Mobix Labs is an emerging growth company.
Mobix Labs, Inc. filed an 8-K to furnish its quarterly financial results for the fiscal quarter ended June 30, 2024.
📋 Key Facts
- The filing is a standard announcement of quarterly earnings (Item 2.02).
- Reporting period: Fiscal quarter ended June 30, 2024.
- Filing date: August 21, 2024.
- The company includes Exhibit 99.1 containing the press release of financial results.
Mobix Labs, Inc. entered into a $4.0 million private placement agreement with an institutional investor involving the issuance of pre-funded warrants and various series of common warrants. The offering includes significant potential dilution through multiple layers of warrants and requires stockholder approval for certain exercises.
🚩 Red Flags
- Significant potential dilution: The issuance of millions of warrants (Pre-funded, Series A, Series B, and Placement Agent Warrants) represents a massive increase in potential share count.
- Complex warrant structure: Multiple layers of warrants with different expiration dates and exercise prices can complicate the capital structure.
- Requirement for stockholder approval: The company is obligated to seek shareholder approval for the issuance/exercise of certain securities within 90 days, creating regulatory and governance uncertainty.
📋 Key Facts
- Total gross proceeds from the private placement: approximately $4.0 million.
- Issuance of Pre-Funded Warrants to purchase up to 2,877,698 shares at an exercise price of $0.001 per share.
- Issuance of Series A and Series B warrants for the same number of shares (2,877,698 each).
- PIPE Common Warrants have an exercise price of $1.39 per share.
- Placement Agent (H.C. Wainwright & Co., LLC) to receive 7% cash fee, 1% management fee, and $85,000 in expenses.
- The company must obtain stockholder approval within 90 days of the offering closing.
Mobix Labs, Inc. filed an 8-K to furnish a mid-quarter business update issued on June 10, 2024.
📋 Key Facts
- The filing is a formal announcement of a mid-quarter business update.
- The report date is June 10, 2024.
- The company is an emerging growth company as defined by the SEC.
Mobix Labs, Inc. has completed its business combination to acquire RaGE Systems, Inc., a radio frequency design and manufacturing services provider. The transaction involves an aggregate consideration of approximately $12 million, consisting of equity and cash components.
🚩 Red Flags
- Significant future cash outflows ($1.8M total scheduled for late 2024/early 2025) which may impact liquidity.
- Potential dilution through the issuance of over 3.2 million shares and potential earn-out stock.
📋 Key Facts
- Closing Date: May 21, 2024
- Acquisition target: RaGE Systems, Inc.
- Total aggregate consideration: Approximately $12.0 million
- Equity component: Issuance of 3,214,045 shares of Class A common stock to RaGE Systems stockholders
- Cash component (fixed): $2.0 million total ($0.2M paid at closing; $1.0M due Nov 15, 2024; $0.8M due April 15, 2025)
- Earn-out component: Up to $8.0 million in cash and stock based on achievement of milestones over eight fiscal quarters
- The shares were issued under Section 4(a)(2) exemption from registration.
Mobix Labs, Inc. filed an 8-K to furnish its quarterly press release regarding financial results for the fiscal quarter ended March 31, 2024.
📋 Key Facts
- Reporting period: Fiscal quarter ended March 31, 2024.
- Filing date: May 14, 2024.
- The filing includes a press release (Exhibit 99.1) detailing results of operations and financial condition.
Mobix Labs, Inc. entered into a definitive agreement to acquire RaGe Systems, Inc., a specialist in RF joint design and manufacturing for 5G and defense sectors, for an aggregate consideration of $12 million.
🚩 Red Flags
- Significant potential dilution via $10M stock issuance and up to $8M in contingent earn-outs.
- The transaction involves an unregistered sale of equity securities relying on Section 4(a)(2) exemption.
📋 Key Facts
- Total transaction value: $12,000,000.
- Consideration structure: $10,000,000 in Mobix Labs Class A Common Stock and $2,000,000 in cash.
- Cash payment schedule: $200,000 at closing; $1,000,000 on Nov 15, 2024; $800,000 on April 15, 2025.
- Potential earn-out payments of up to $8,000,000 based on financial metrics over eight fiscal quarters.
- Expected closing date: May 2024.
- RaGE Systems stockholders will receive 'piggy-back' registration rights.
Mobix Labs, Inc. announced the strategic acquisition of RaGE Systems, Inc. via a press release on May 9, 2024.
📋 Key Facts
- Acquisition of RaGE Systems, Inc. announced on May 9, 2024.
- The acquisition is described as 'strategic' in the accompanying press release.
- Filing includes an exhibit (99.1) containing the full details of the transaction.
Mobix Labs, Inc. entered into a Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC for the potential sale of up to $100 million in newly issued Class A common stock over 36 months. The agreement includes an equity drawdown mechanism (at-the-market style) subject to specific price thresholds and volume limitations.
🚩 Red Flags
- Highly dilutive potential: The company has authorized up to $100M in new equity, which could significantly dilute existing shareholders.
- At-the-market (ATM) structure: The agreement allows the company to sell shares at a discount to VWAP, often associated with downward pressure on stock price.
- Low threshold price: The $0.50 threshold for continued sales suggests the company may be operating in a low-stock-price environment.
📋 Key Facts
- Total potential offering amount: Up to $100,000,000 in Class A common stock.
- Counterparty: B. Riley Principal Capital II, LLC.
- Term length: Up to 36 months from the Commencement Date.
- Pricing mechanism: VWAP (Volume Weighted Average Price) less a fixed 3.0% discount.
- Threshold Price: $0.50 minimum closing price required for purchases to proceed.
- Issuance Cap: Limited to 19.99% of outstanding shares unless stockholder approval is obtained or the average share price exceeds $2.10.
- Beneficial ownership limit: B. Riley and affiliates are capped at owning more than 4.99% of outstanding shares.
Mobix Labs, Inc. filed an 8-K to provide a mid-quarter business update via a press release. The filing does not contain substantive financial changes or material agreements but serves as a vehicle for regulatory compliance regarding information disclosure.
📋 Key Facts
- The company issued a press release on March 11, 2024, providing a mid-quarter business update.
- The filing is made pursuant to Item 7.01 (Regulation FD Disclosure).
- Information provided under Item 7.01 is furnished but not considered 'filed' for purposes of Section 18 liability.
Mobix Labs, Inc. announced significant downward adjustments to its warrant exercise prices and redemption triggers following a business combination. Additionally, the company appointed Michael Long to the Board via a $3 million private placement that includes anti-dilution protections for the investor.
🚩 Red Flags
- Significant downward adjustment of warrants (indicative of massive dilution and poor stock performance post-merger).
- The warrant price reduction ($5.79) is significantly below the recent issuance price ($5.03) relative to historical levels, signaling extreme volatility.
- Related-party transaction: New director Michael Long participated in a $3M private placement with anti-dilution/downward adjustment mechanisms (the 'Adjustment Period VWAP' clause).
- Issuance of low-cost PIPE Warrants ($0.01 exercise price) to a new director.
📋 Key Facts
- Warrant exercise price adjusted from $11.50 to $5.79 per share.
- Redemption trigger price adjusted from $18.00 to $9.06 per share.
- Adjustments triggered by a business combination and stock price performance (Market Value of $4.93).
- Michael Long appointed as Class III director; he purchased 300,000 shares at $10.00/share ($3M total) via subscription agreement.
- Mr. Long received a PIPE Warrant for 100,000 shares with an exercise price of $0.01 per share.